Symetis Gets $25.8 Million In Financing

Symetis SA, a Swiss company that develops transcatheter aortic valve implantation systems, has raised CHF 25 million ($25.8 million). Endeavour Vision and NBGI Ventures co-led the financing round. Truffle Capital, Novartis Venture Fund, Wellington Partners, Vinci Capital - Renaissance PME, Banexi Ventures and BiomedInvest were returning investors.

North AmericaUSBriefs